-
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
13 Feb 2024 00:56 GMT
… Silver Creek Pharmaceuticals, a clinical-stage biotechnology company focused … Development, at Sepracor. Prior to joining Sepracor, Dr. Corrigan … Clinical Research and Experimental Medicine.
Dr. Corrigan serves … study for the treatment of acute ischemic stroke …
-
Krouzon Pharmaceuticals Enters R&D and Commercial Manufacturing Agreement with TCG GreenChem
10 Jan 2024 20:00 GMT
… -- Krouzon Pharmaceuticals, Inc., a biotechnology company focusing on … -doctoral research at the Yale School of Medicine … known pharmaceutical products for Boehringer Ingelheim Pharmaceuticals, Inc., Sepracor, Inc … s current drug candidate for the treatment of …
-
Marlborough drugmaker lays off hundreds amidst major corporate restructuring
03 May 2023 20:02 GMT
Sunovion Pharmaceuticals and two other subsidiaries … soon-to-be-combined Marlborough drugmaker Sumitomo Pharma America will … in November.
The Japanese drugmaker announced on April 3 it … release announcing the agreement. Sepracor changed its name to Sunovion …
-
Shuttle Pharmaceuticals Provides Third Quarter 2022 Corporate Update
16 Nov 2022 02:45 GMT
… drug product for testing in clinical trials … known pharmaceutical products for Boehringer Ingelheim Pharmaceuticals, Inc., Sepracor, … Director at Shuttle Pharmaceuticals.
Treatment with HDAC … Georgetown University Medical Center, Shuttle Pharmaceuticals is …
-
Shuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridine
21 Sep 2022 01:16 GMT
… trials, to establish the data necessary for the FDA … -drug designation for Ropidoxuridine for the treatment … known pharmaceutical products for Boehringer Ingelheim Pharmaceuticals, Inc., Sepracor, … University Medical Center, Shuttle Pharmaceuticals is …
-
Cognesy Therapeutics Announces Senior Leadership Team to Advance Neuroplasticity Drug Discovery Platform for Neuropsychiatric Disorders
25 Aug 2022 13:52 GMT
… address the worldwide medical need for novel … Pharma, Acorda Therapeutics, Sepracor and Janssen Pharmaceuticals.
Peter S. … drug discovery and development experience in the pharmaceutical and biotech … novel drugs that induce neuroplasticity for the treatment …
-
Less Than a Quarter of Those with Depression Respond to Treatment in Real Life
27 Jun 2022 10:00 GMT
… but in clinical trials, the placebo effect … from aggressive drug treatment in this study.
Antidepressants have … MDD and its treatment.”
**
Pharmaceutical giant Lundbeck funded … , Richter, Roche, Sanofi, Sepracor, Servier, Shire, Synosis, Takeda …
-
Asthma and COPD Drugs Market to Worth $50.35 Billion by 2026 | By Product, Business & Application
21 Jan 2022 13:49 GMT
… Medical Association (EMA), the U.S. Food and Drugs Administration (FDA … in the treatment of asthma … AG (Switzerland), Teva Pharmaceutical Industries (Israel), … Inc. Almirall SA. Genentech Inc. Sepracor, Inc. Skyepharma plc.
𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗣𝗿𝗼𝗰𝘂𝗿𝗶𝗻𝗴 …
-
Global Asthma Drugs Market Growth 2021 Corporate Strategy Analysis, Upcoming Trends, Applications, Market Share, Demand and Forecast to 2026
16 Aug 2021 11:21 GMT
… MAP Pharmaceuticals, Inc. ● Genentech Inc. ● Roche ● GlaxoSmithKline ● Pfizer ● Merck ● Sepracor, Inc … term Control Medications ● Quick-relief Medications (Rescue Medications) ● Medications for Allergy … Drugs Consumption and Growth Rate of Biotechnology …